Marie‐Claude Granger

Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases

Stephen Claridge, Franck Raeppel, Marie‐Claude Granger et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors

Stéphane Raeppel, Stephen Claridge, Oscar Saavedra et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases

Oscar Saavedra, Stephen Claridge, Lijie Zhan et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Increased Felkin−Anh Selectivity Using AlMe₃in the Addition of Vinyllithiums to α-Chiral Aldehydes:  Do “Ate” Complexes Play Any Role?

Claude Spino, Marie‐Claude Granger, Marie‐Claude Tremblay · Organic Letters · 2002 · 16 citations

Natural Sciences, Chemistry, Organic Chemistry +5

Increased Felkin–Anh selectivity in nucleophilic additions to α-chiral aldehydes using vinylalanes

Claude Spino, Marie‐Claude Granger, Luc Boisvert et al. · Tetrahedron Letters · 2002 · 12 citations

Natural Sciences, Chemistry, Medicinal Chemistry +4